The cytotoxic activity of combined OC-LP treatment was assessed using the apoptotic marker Annexin V and the oncotic marker PI in treated breast cancer cells applying flow cytometry (Figure 4A). The gene discussed is ANXA5; the disease is breast carcinoma.